$1.45
-0.07-4.61%
Pre-Market: Feb 28, 4:04 AM EDT
Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
MetaVia Stock Price, Quotes and Forecasts | NASDAQ:MTVA | Benzinga
Explore MetaVia stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MTVA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy MetaVia (MTVA) stock?
You can purchase shares of MetaVia (NASDAQ:MTVA) through any online brokerage.
Who are MetaVia (MTVA) competitors?
Other companies in MetaVia’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB) and Imunon (NASDAQ:IMNN).
What is the forecast, or price target, for MetaVia (MTVA) stock?
MetaVia has a consensus price target of $12.00.
What is the current price for MetaVia (MTVA)?
The stock price for MetaVia (NASDAQ: MTVA) is $1.45 last updated February 28, 2025 at 4:04 AM EST.
Does MetaVia (MTVA) pay a dividend?
There are no upcoming dividends for MetaVia.
When is MetaVia (NASDAQ:MTVA) reporting earnings?
MetaVia’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is MetaVia (MTVA) going to split?
There is no upcoming split for MetaVia.
What sector and industry does MetaVia (MTVA) operate in?
MetaVia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.